LIVER FIBROSIS PROGRESSION AND LYSOSOMAL ACID LIPASE ACTIVITY IN PATIENTS WITH METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE

被引：0
|
作者：
Colantoni, Alessandra [1 ]
Pastori, Daniele [1 ]
Cocomello, Nicholas [1 ]
Angelico, Francesco [1 ]
Del Ben, Maria [1 ]
Baratta, Francesco [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SaaG087
引用
收藏
页数：2
相关论文
共 50 条
  • [41] LYSOSOMAL ACID LIPASE ACTIVITY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Pastori, D.
    Baratta, F.
    Polimeni, L.
    Piemonte, F.
    Tozzi, G.
    Di Santo, S.
    Salzano, D.
    Pani, A.
    Violi, F.
    Del Ben, M.
    Angelico, F.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S742 - S742
  • [42] IMPACT OF SARCOPENIA AND ADVANCED FIBROSIS ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE
    Lee, Jae Chang
    Kim, Kye Whon
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Kweon, Young Oh
    Tak, Won Young
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY, 2022, 76 : S809 - S809
  • [43] From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology
    Malnick, Stephen David Howard
    Zamir, Doron
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (06)
  • [44] Histological and clinical disease progression in patients with metabolic dysfunction-associated steatotic liver disease using paired liver biopsy
    Ekelik, Merve
    Gokce, Dilara Turan
    Gumussoy, Mesut
    Kiremitci, Saba
    Bodakci, Emin
    Yilmaz, Volkan
    Karayel, Sevinc Tugce
    Duman, Serkan
    Ellik, Zeynep Melekoglu
    Ozercan, Abdullah Mubin
    Er, Ramazan Erdem
    Karakaya, Fatih
    Gokcan, Hale
    Elhan, Atilla
    Savas, Berna
    Toruner, Murat
    Idilman, Ramazan
    JOURNAL OF HEPATOLOGY, 2024, 80 : S479 - S479
  • [45] Gut microbiome composition and metabolic activity in metabolic-associated fatty liver disease
    Zhang, Daya
    Wang, Qi
    Li, Da
    Chen, Shiju
    Chen, Jinrun
    Zhu, Xuli
    Bai, Feihu
    VIRULENCE, 2025, 16 (01)
  • [46] Sequential diagnostic approach utilizing FIB-4 and ELF for predicting advanced fibrosis in metabolic-associated steatotic liver disease
    Kang, Yeo Wool
    Baek, Yang-Hyun
    Moon, Sang Yi
    JOURNAL OF HEPATOLOGY, 2024, 80 : S552 - S553
  • [47] The Role of Fibroscan in Assessment of Liver Fibrosis in Patients With Diabetes Mellitus and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
    Menon, Raakhi
    Movva, Giri
    Garza, Devin
    Butt, Edward
    Zhang, Julia
    Khan, Kashif
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1240 - S1240
  • [48] IDENTIFYING CANDIDATES FOR LIVER BIOPSY IN METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE: MACHINE LEARNING-BASED PREDICTIVE MODELS
    Kim, Dong Yun
    Lee, Hye Won
    Chun, Ho Soo
    Lee, Jae Seung
    Kim, MiNa
    Yun, Hae Ryong
    Park, Jun Yong
    HEPATOLOGY, 2024, 80 : S593 - S594
  • [49] Navigating the landscape of metabolic-associated steatotic liver disease treatment: aspirin as a potential game changer
    Narang, Saransh
    Trivedi, Yash Vardhan
    Chhetri, Anniesha Bista
    Anamika, F. N. U.
    Shah, Priyanshi
    Jain, Rohit
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (01) : 10 - 14
  • [50] Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
    Mignini, Irene
    Galasso, Linda
    Piccirilli, Giulia
    Calvez, Valentin
    Termite, Fabrizio
    Esposto, Giorgio
    Borriello, Raffaele
    Miele, Luca
    Ainora, Maria Elena
    Gasbarrini, Antonio
    Zocco, Maria Assunta
    ANTIOXIDANTS, 2024, 13 (12)
12345